Literature DB >> 31385080

Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies.

Adam Maundrell1, Susanna Proudman2,3, Vidya Limaye4,5.   

Abstract

We sought to determine the prevalence of additional connective tissue diseases (CTDs) in patients with idiopathic inflammatory myopathies (IIM), and to study the muscle biopsy patterns in various clinico-serologic subsets of myositis. We undertook a retrospective cohort study of 648 patients with a histological diagnosis of IIM. The following was determined from the South Australian Myositis Database: presence of associated CTDs, histological details and presence of myositis-specific (MSA) or myositis-associated (MAA) antibodies. Among patients with IIM, a significantly greater proportion had systemic sclerosis 32/648 (4.9%) than mixed connective tissue disease (12/648, p = 0.003), primary Sjogren's syndrome (12/648, p = 0.003), systemic lupus erythematosus (10/648, p < 0.001) or rheumatoid arthritis (6/648, p = 0.0001). Polymyositis was the most common IIM diagnosis regardless of the presence or absence of CTD. MSA/MAA was more commonly detected in those with systemic sclerosis than those with IIM alone (OR 5.35, p < 0.005). The higher prevalence of SSc (compared with other CTDs) in IIM, together with the more frequent detection of autoantibodies in this group, suggests that these conditions may be linked.

Entities:  

Keywords:  Connective tissue disease; Myositis; Myositis overlap; Scleroderma; Systemic sclerosis

Mesh:

Substances:

Year:  2019        PMID: 31385080     DOI: 10.1007/s00296-019-04411-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.

Authors:  Andrea Váncsa; Lajos Gergely; Andrea Ponyi; Gabriella Lakos; Júlia Németh; Péter Szodoray; Katalin Dankó
Journal:  Joint Bone Spine       Date:  2010-02-25       Impact factor: 4.929

2.  Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.

Authors:  Yves Troyanov; Ira N Targoff; Jean-Luc Tremblay; Jean-Richard Goulet; Yves Raymond; Jean-Luc Senécal
Journal:  Medicine (Baltimore)       Date:  2005-07       Impact factor: 1.889

3.  Clinical and serological associations of anti-Ku antibody.

Authors:  H M Cooley; B J Melny; R Gleeson; T Greco; T W Kay
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

4.  A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.

Authors:  Vidya S Limaye; Sue Lester; Peter Bardy; Philip Thompson; Sally Cox; Peter Blumbergs; Peter Roberts-Thomson
Journal:  Rheumatol Int       Date:  2010-12-02       Impact factor: 2.631

5.  Clinical and laboratory features of scleroderma patients developing skeletal myopathy.

Authors:  Yoshihiro Mimura; Hironobu Ihn; Masatoshi Jinnin; Yoshihide Asano; Kenichi Yamane; Kunihiko Tamaki
Journal:  Clin Rheumatol       Date:  2004-08-20       Impact factor: 2.980

Review 6.  Latest update on the Ro/SS-A autoantibody system.

Authors:  J Schulte-Pelkum; M Fritzler; M Mahler
Journal:  Autoimmun Rev       Date:  2009-02-12       Impact factor: 9.754

7.  Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.

Authors:  B Rozman; S Cucnik; S Sodin-Semrl; L Czirják; C Varjú; O Distler; D Huscher; M Aringer; G Steiner; M Matucci-Cerinic; S Guiducci; B Stamenkovic; A Stankovic; T Kveder
Journal:  Ann Rheum Dis       Date:  2007-12-06       Impact factor: 19.103

Review 8.  Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria.

Authors:  Frank L Mastaglia; Beverley A Phillips
Journal:  Rheum Dis Clin North Am       Date:  2002-11       Impact factor: 2.670

Review 9.  Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.

Authors:  Harsha Gunawardena; Zoe E Betteridge; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

Review 10.  Idiopathic inflammatory myopathies.

Authors:  V S Limaye; P Blumbergs; P J Roberts-Thomson
Journal:  Intern Med J       Date:  2009-03       Impact factor: 2.048

View more
  9 in total

1.  Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort.

Authors:  R Naveen; Upendra Rathore; Vikas Agarwal; Latika Gupta
Journal:  Rheumatol Int       Date:  2021-01-10       Impact factor: 2.631

Review 2.  Biologic therapy in the idiopathic inflammatory myopathies.

Authors:  Thomas Khoo; Vidya Limaye
Journal:  Rheumatol Int       Date:  2019-11-04       Impact factor: 2.631

3.  The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus.

Authors:  John D Pauling; Sarah Skeoch; Julie J Paik
Journal:  Indian J Rheumatol       Date:  2021-01-18

4.  [Clinical and immunological characteristics of 88 cases of overlap myositis].

Authors:  Y S Xiao; F Y Zhu; L Luo; X Y Xing; Y H Li; X W Zhang; D H Shen
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

5.  Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables.

Authors:  Luis Fernando Valladales-Restrepo; Ana Camila Delgado-Araujo; Brayan Stiven Aristizábal-Carmona; Lina María Saldarriaga-Rivera; Jorge Enrique Machado-Alba
Journal:  Int J Rheumatol       Date:  2022-07-05

Review 6.  Secondary Causes of Myositis.

Authors:  Sarah H Berth; Thomas E Lloyd
Journal:  Curr Treat Options Neurol       Date:  2020-10-06       Impact factor: 3.598

7.  Clinical, Serological, and Genetic Characteristics of a Hungarian Myositis-Scleroderma Overlap Cohort.

Authors:  Katalin Szabó; Levente Bodoki; Melinda Nagy-Vincze; Tibor Béldi; Anett Vincze; Erika Zilahi; József Varga; Gabriella Szűcs; Katalin Dankó; Zoltán Griger
Journal:  Biomed Res Int       Date:  2022-05-02       Impact factor: 3.246

8.  Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort.

Authors:  Angeles S Galindo-Feria; Begum Horuluoglu; Jessica Day; Catia Fernandes-Cerqueira; Edvard Wigren; Susanne Gräslund; Susanna Proudman; Ingrid E Lundberg; Vidya Limaye
Journal:  Rheumatology (Oxford)       Date:  2022-10-06       Impact factor: 7.046

Review 9.  The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.

Authors:  Ioana Bratoiu; Alexandra Maria Burlui; Anca Cardoneanu; Luana Andreea Macovei; Patricia Richter; Gabriela Rusu-Zota; Ciprian Rezus; Minerva Codruta Badescu; Andreea Szalontay; Elena Rezus
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.